What is Eton Pharmaceuticals, Inc.'s R&D?

Eton Pharmaceuticals, Inc. (ETON) reported R&D of $1.88M in Q1 2026.

How has Eton Pharmaceuticals, Inc.'s R&D changed year-over-year?

Eton Pharmaceuticals, Inc.'s R&D increased by 61.5% year-over-year, from $1.16M to $1.88M.

What is the long-term trend for Eton Pharmaceuticals, Inc.'s R&D?

Over 3 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s R&D has grown at a 7.6% compound annual growth rate (CAGR), from $6.24M to $7.77M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Eton Pharmaceuticals, Inc. ETON R&D

R&D at other companies

HRO

HarrowHROW

$5.9M+94.8%

Zevra Therapeutics, Inc.ZVRA

$4.39M+34.8%

XER

Xeris Biopharma Holdings, Inc.XERS

$8.78M+13.3%

Ultragenyx PharmaceuticalRARE

$187M+12.7%

ANI PharmaceuticalsANIP

$10.6M+0.3%

Crinetics PharmaceuticalsCRNX

$100.08M+31.3%

Other financials

Income statement

See full

Revenue$24.3M+40.4%

Gross profit$14.7M+49.4%

Operating income$2.4M+614%

Net income$1.6M+199%

EPS (diluted)$0.05+183%

Balance sheet

See full

Cash & equivalents$19.7M+12.9%

Total debt$31.3M+3.7%

Total equity$30.6M+25.2%

Total assets$97.7M+16.3%

Cash flow

See full

Operating cash flow$7.4M+254%

CapEx$75.0K—

Free cash flow$7.3M+251%

Valuation

See full

Market cap$953.8M+162%

Enterprise value$965.4M+156%

P/S11×+3.4×

Profitability

See full

Gross margin54.8%-3.7pp

Operating margin-15.1%—

Net margin-9.5%-2.7pp

FCF margin17.1%—

Returns & leverage

See full

Return on equity-34.2%+0.9pp

Debt / equity1×-0.2×

Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s R&D?: Eton Pharmaceuticals, Inc. (ETON) reported R&D of $1.88M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s R&D changed year-over-year?: Eton Pharmaceuticals, Inc.'s R&D increased by 61.5% year-over-year, from $1.16M to $1.88M.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s R&D?: Over 3 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s R&D has grown at a 7.6% compound annual growth rate (CAGR), from $6.24M to $7.77M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.